$246 Million is the total value of Kopp Family Office, LLC's 13 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NeoGenomics Inc. | $165,763,000 | +39.0% | 3,078,815 | -4.8% | 67.51% | +4.2% |
| VCEL | Vericel Corporation | $35,535,000 | +66.7% | 1,150,735 | 0.0% | 14.47% | +25.0% | |
| HZNP | Buy | Horizon Therapeutics Public Limited Company | $31,965,000 | -3.7% | 436,975 | +2.2% | 13.02% | -27.8% |
| FIVN | Five9, Inc. | $11,602,000 | +34.5% | 66,525 | 0.0% | 4.72% | +0.8% | |
| XENT | Sell | Intersect ENT Inc. | $229,000 | -81.9% | 10,000 | -87.1% | 0.09% | -86.5% |
| IVV | ISHARES TRcore s&p500 etf | $110,000 | +12.2% | 292 | 0.0% | 0.04% | -15.1% | |
| ISTB | ISHARES TRcore 1 5 yr usd | $106,000 | 0.0% | 2,050 | 0.0% | 0.04% | -25.9% | |
| IEFA | ISHARES TRcore msci eafe | $81,000 | +14.1% | 1,178 | 0.0% | 0.03% | -15.4% | |
| IAGG | ISHARES TRcore intl aggr | $44,000 | 0.0% | 783 | 0.0% | 0.02% | -25.0% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $40,000 | 0.0% | 764 | 0.0% | 0.02% | -27.3% | |
| IJH | ISHARES TRcore s&p mcp etf | $34,000 | +25.9% | 147 | 0.0% | 0.01% | -6.7% | |
| IJR | ISHARES TRcore s&p scp etf | $19,000 | +26.7% | 207 | 0.0% | 0.01% | 0.0% | |
| IEMG | ISHARES TRcore msci emkt | $20,000 | +17.6% | 316 | 0.0% | 0.01% | -11.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.